Loading clinical trials...

AIM2ACT: A Mobile Health Tool to Help Adolescents Self-Manage Asthma | Clinical Trials | Clareo Health

ACTIVE_NOT_RECRUITINGNA

AIM2ACT: A Mobile Health Tool to Help Adolescents Self-Manage Asthma

NCT04448002•University of Florida

Summary

The aim is to test the efficacy of AIM2ACT and long-term maintenance of treatment effects in a fully-powered randomized controlled trial with 160 early adolescents with poorly controlled persistent asthma, ages 12-15 years, and a caregiver

Eligibility

Age

12 - 70 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Adolescent is 12-15 years old
•2. Caregiver is between 18-70 years-old
•3. Adolescent lives in the residence of caregiver
•4. Adolescent and caregiver can speak and read English
•5. (a) Adolescent has been diagnosed as having asthma, OR (b) Doctor has stated the adolescent has asthma, OR (c) Adolescent has had breathing problems in the past 12 months
•6. Adolescent has had an active inhaled corticosteroid prescription for ≥ 4 weeks
•7. (a) During the past 14 days (that is, during the past fourteen 24-hour periods that include daytime and nighttime), the adolescent has experienced one or more of the following: (i) Asthma symptoms such as wheezing, shortness of breath, or tightness in the chest, or cough on more than 4 separate days; (ii) Woken up because of asthma symptoms such as wheezing, shortness of breath, or tightness in the chest, or cough on 1 or more separate nights; (iii) Had to slow down or stop play or usual activities or missed school because of asthma, wheezing, or tightness in the chest, or cough on more than 4 separate days; (iv) Used any asthma rescue medicine (sometimes called a quick relief medicine) on more than 4 separate days
•* OR
•(b) In the past year, adolescent has had one or more of the following: (i) 2 or more exacerbations requiring oral systemic corticosteroids; (ii) 2 or more emergency department visits; (iii) 1 hospitalization; (iv) 2 or more urgent medical care visits due to asthma
•* OR
+1 more criteria

Exclusion Criteria

•Families will be excluded if:
•1. The family is currently involved in an asthma management intervention above and beyond usual care, OR
•2. Adolescent is unable to complete study procedures independently.

Locations (2)

UF Health Pediatrics

Gainesville, Florida, United States

Nemours Children's Hospital

Jacksonville, Florida, United States

Key Dates

Start Date

April 23, 2021

Primary Completion Date

March 31, 2026

Completion Date

March 31, 2026

Last Updated

March 13, 2025

Enrollment

320

ESTIMATED participants

Conditions

Asthma

Interventions

AIM2ACT

BEHAVIORAL

mHealth Attention Control Condition

BEHAVIORAL

NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)

NCT02327897

Asthma

View study

RECRUITINGNA

Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)

NCT07486401

Asthma ExacerbationsBiomarkers / Blood+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 13, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

AIM2ACT: A Mobile Health Tool to Help Adolescents Self-Manage Asthma

Inclusion Criteria

Exclusion Criteria

NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)

Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma

To Assess the Management of Patients on Global Initiative of Asthma (GINA) Step 4 and 5 Treatment in Hong Kong

A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma